During the past decade, Hospital Sirio Libanes conducted 39 clinical trials. In the 10-year time frame, 39 clinical trials started and 10 clinical trials were completed, i.e. on average, 25.6% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 7 clinical trials were completed. i.e. 41.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Sirio Libanes" #1 sponsor was "Hospital Sirio-Libanes" with 18 trials, followed by "Hoffmann-La Roche" with 12 trials sponsored, "CancerVax Corporation" with 2 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored and "Instituto do Cancer do Estado de São Paulo" with 2 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Sirio Libanes" #1 collaborator was "Brazilian Research In Intensive Care Network" with 2 trials as a collaborator, "Fundação Faculdade de Medicina" with 2 trials as a collaborator, "Hospital Israelita Albert Einstein" with 2 trials as a collaborator, "Hospital Moinhos de Vento" with 2 trials as a collaborator and "Hospital Sirio-Libanes" with 2 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Sirio Libanes" are "Breast Cancer" (4 trials), "Hepatocellular Carcinoma" (3 trials), "COVID-19" (2 trials), "Cleft Lip and Palate" (2 trials) and "Crohn Disease" (2 trials). Many other conditions were trialed in "Hospital Sirio Libanes" in a lesser frequency.

Most popular intervention types in "Hospital Sirio Libanes" are "Drug" (27 trials), "Other" (6 trials), "Biological" (5 trials), "Device" (4 trials) and "Procedure" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Etrolizumab" (4 trials), "Atezolizumab" (3 trials), "CancerVax vaccine (CANVAXIN)" (2 trials) and "Mirikizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Sirio Libanes" are 46 trials for "All" genders, 4 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital Sirio Libanes". 1 are not yet recruiting, 10 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 25 completed trials in Hospital Sirio Libanes, 1 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Sirio Libanes, 1 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 12 trials that are defined as “Not Applicable".

Hospital Sirio Libanes has several departments that took part in Clinical trials: "Hospital Sirio Libanes; Centro de Oncologia" - 6 trials